| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,325 |
2,253 |
$90K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,352 |
1,331 |
$74K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
333 |
186 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
129 |
129 |
$10K |
| 99222 |
Initial hospital care, per day, moderate complexity |
98 |
98 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,902 |
1,663 |
$6K |
| 99223 |
Prolong inpt eval add15 m |
25 |
25 |
$3K |
| 99221 |
|
48 |
48 |
$3K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
724 |
667 |
$2K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
23 |
12 |
$897.82 |
| 62323 |
|
14 |
12 |
$577.64 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
180 |
178 |
$558.24 |
| J3490 |
Unclassified drugs |
183 |
155 |
$444.41 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
289 |
243 |
$132.06 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
119 |
118 |
$57.50 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
48 |
40 |
$7.32 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
61 |
50 |
$4.08 |
| J2704 |
Injection, propofol, 10 mg |
33 |
26 |
$1.94 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,630 |
2,545 |
$0.02 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
1,228 |
1,176 |
$0.02 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
826 |
788 |
$0.02 |
| 36410 |
|
18 |
14 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
56 |
43 |
$0.00 |
| 4004F |
|
2,517 |
2,433 |
$0.00 |